Microarrays on Zageno
Applications of microarrays
Tumor formation involves changes of numerous genes, and a DNA (cDNA) microarray can provide a platform which allows medical scientists to have a better understanding of gene expression in different clinical samples. Some types of cancer such as breast cancer are highly heterogeneous containing various molecular and clinical subtypes.
Different clinical subtypes of cancer can show different prognosis to the same treatment due to variation in gene expression. However, exactly how cancer heterogeneity affects prognosis and treatment response of patients has yet to be fully understood. Nonetheless, DNA microarray technologies provide medical scientists an opportunity to analyze and compare expression profile of different cancer clinical/molecular subtypes. By comparing gene expression profiles between samples from different cancer subtypes and normal tissues using microarray technologies, scientists can identify specific genes that are expressed/silenced in each molecular subtype of cancer and scientists can understand how particular genes affect treatment response. Ultimately, scientists can use this technology to identify putative drug targets for cancer treatment.
How to perform a DNA microarray analysis
Multiple preparation steps are required to perform a successful DNA microarray for comparing genes expression in different samples.
Firstly, mRNA must be purified from both experimental sample (e.g., cancer cells) and referee sample (e.g., normal healthy cells) by using an organic solvent. Secondly, mRNA from experimental and referee sample are converted to complementary DNA (cDNA) by reverse transcriptase, and fluorescent probes of different colors are used to label the cDNA samples.
The color of fluorescent probes used in experimental and referee samples should be different (e.g., green fluorescent for referee sample and red fluorescent for experimental sample). Afterward, cDNA from the two samples (from cancer and healthy cells) are added onto the microarray chip. cDNA from the samples hybridize to the complementary strand on the microarray so that each spot on the microarray contains a specific nucleotide sequence which represents a particular gene. The microarray will then be washed to wash off excess cDNA that did not hybridize to the complementary strand. Finally, the microarray will be analyzed in a scanner (exposed to laser) to examine fluorescent of every single spot for red and green. The results of red and green fluorescent will be merged.
What does the result of DNA microarray means?
The fluorescence intensity is positively correlated to the amount of cDNA from each sample. The appearance of red fluorescence in a spot means the gene is highly expressed in experimental sample (e.g., tumor cells) while the appearance of green fluorescence in a spot means the gene is actively expressed in referee sample (healthy cells). For a gene that is highly expressed in both the experimental and referee samples, the spot will be yellow in color when exposed to the laser.
One of the limitations of DNA microarrays is that expression of mRNA is not fully correlated to protein expression profile of organisms. Therefore, protein microarrays have been developed to examine and compare protein expression profiles of different samples. The principle of DNA and protein microarrays is similar, but antibodies are used to capture/hybridize with target proteins in protein microarray.
Compare Protein Microarrays for Cancer Screening
With our compare function, you can avoid all the time and energy wasted sifting through multiple web pages from different suppliers. At ZAGENO you can clearly see kits side-by-side, with the relevant attributes for each kit neatly in line for easy selection of the best product for you.
Click on the comparison below for a clearer view!
For example, this comparison shows:
- that the MULTI-TUMOR TISSUE ARRAY and METASTATIC CANCER TISSUE ARRAY Kits from Abcam are the cheapest.
- that the PROTOARRAY® HUMAN PROTEIN MICROARRAY Kit from Invitrogen includes over 9000 unique human proteins and is compatible with most fluorescent microarray scanners.
This comparison clearly exemplifies how every kit has strengths and weaknesses. Depending on what features you require for your experiment, these details should enable you to make an informed decision on the right kit for you.
The ZAGENO comparison does not highlight one kit to be better than the other, as the kit of choice may vary between researchers - depending on each individual's preferred attributes. The best kit is the one that meets your needs - ZAGENO allows you to make an informed decision with minimum effort.
Check out our How It Works page for a guide to using the comparison function.
Genome BC/ Youtube